Form 4: National Health Investors SVP Acquires Shares and Stock Options
SEC Form 4 Filing
Kristin Sallee Gaines, SVP/Chief Transaction Officer of National Health Investors, reports acquisition of common stock and stock options.
Summary
- Kristin Sallee Gaines, a Senior Vice President and Chief Transaction Officer at National Health Investors Inc., filed a Form 4.
- The filing details changes in her beneficial ownership of the company's securities.
- On March 3, 2025, Gaines acquired 4,000 shares of common stock.
- She also acquired stock options to purchase shares of common stock at a price of $73.34, exercisable at various dates in 2026, 2027 and 2028.
- Following these transactions, Gaines directly owns 61,944 shares of common stock.
- She also holds options to purchase a total of 8,333 shares exercisable on 03/03/2025, 8,333 shares exercisable on 03/03/2026, 8,334 shares exercisable on 03/03/2027, and various other options from previous years.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by an executive is generally viewed as a positive sign, but it's a routine transaction.
Positives
- The acquisition of shares and stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's valuation and future prospects.
Stakeholder Impact
- The reported transactions provide shareholders with insight into the actions of a key company executive.
Key Dates
| Date | Description |
|---|---|
| 02/25/2022 | Date of stock option grant with exercise price of $53.41. |
| 02/24/2023 | Date of stock option grant with exercise price of $54.73. |
| 02/23/2024 | Date of stock option grant with exercise price of $57.76. |
| 03/03/2025 | Date of transaction: Acquisition of common stock and stock options. |
| 03/05/2025 | Date of Form 4 filing. |
| 02/25/2027 | Expiration date for stock options granted on 02/25/2022. |
| 02/24/2028 | Expiration date for stock options granted on 02/24/2023. |
| 02/23/2029 | Expiration date for stock options granted on 02/23/2024. |
| 03/03/2030 | Expiration date for stock options granted on 03/03/2025. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.